Calls
8
#933
Alpha Score 24.4
Lee Jeok-gyu
Strategist, SK Securities
Win Rate
37.5%
return
-1.7%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jul 06
$2381000.00
-29.1%
Samsung Electronics and SK hynix remain core long-term holdings. Even if Q2 earnings miss, any dip would be a buying opportunity because the global semiconductor uptrend is intact. Portfolio discipline favours building positions on weakness.
AI Memory
Long
Jul 06
$451000.00
+14.4%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Batteries & Storage
Long
Jul 06
$216000.00
-6.7%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Grid Equipment
Long
Jul 06
$77400.00
-6.8%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Gaming & Entertainment
Long
Jul 06
$175800.00
+7.8%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Pharma & Biotech
Long
Jul 06
$116100.00
+28.2%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Personal Care
Long
Jul 06
$331000.00
-5.9%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Pharma & Biotech
Long
Jul 06
$212000.00
-15.5%
KOSDAQ has fallen 33% from its peak due to severe liquidity distortions from leveraged ETFs, creating an extreme oversold condition. An eventual normalization will trigger strong rebounds in oversold large-cap KOSDAQ names across biotech, cosmetics, entertainment, and batteries. Specific names with tight stop-loss levels offer attractive risk/reward.
Gaming & Entertainment
Showing 8 of 8 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Lee Jeok-gyu has 8 trade ideas tracked on Buzzberg across 8 tickers since July 2026. Ranked #933 on the Buzzberg Alpha leaderboard. Most covered: 000660.KS, 041510.KQ, 010120.KS.
